Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000286

Director sold 12,000 shares at $80.00 ($960,000)

  • Director acquired 12,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

KLEIN JOSEPH III · Director

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2025-11-25 Exercise or conversion : show line 1 in the form 10b5-1 +4,000 4,000 I
2025-11-25 Sale : show line 2 in the form 10b5-1 −4,000 $80.00 $320,000 0 I
2025-11-25 Exercise or conversion : show line 3 in the form 10b5-1 +4,000 4,000 I
2025-11-25 Sale : show line 4 in the form 10b5-1 −4,000 $80.00 $320,000 0 I
2025-11-25 Exercise or conversion : show line 5 in the form 10b5-1 +4,000 4,000 I
2025-11-25 Sale : show line 6 in the form 10b5-1 −4,000 $80.00 $320,000 0 I
Open-market sales · 12,000 sh · avg $80.00 · $960,000

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2025-11-25 Exercise or conversion : show line 7 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −4,000 8,000 I
2025-11-25 Exercise or conversion : show line 8 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −4,000 4,000 I
2025-11-25 Exercise or conversion : show line 9 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −4,000 0 I
Loading xslF345X05/edgardoc.xml…